Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 19 studies | 27% ± 12% | |
connective tissue cell | 5 studies | 32% ± 11% |
Insufficient scRNA-seq data for expression of MXRA5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 4173.07 | 652 / 653 | 86% | 55.77 | 519 / 605 |
pancreas | 89% | 1862.33 | 292 / 328 | 89% | 100.07 | 159 / 178 |
breast | 80% | 2499.11 | 368 / 459 | 97% | 147.75 | 1082 / 1118 |
lung | 91% | 2360.05 | 524 / 578 | 83% | 61.61 | 958 / 1155 |
stomach | 91% | 1315.73 | 326 / 359 | 81% | 74.71 | 232 / 286 |
ovary | 74% | 1324.74 | 134 / 180 | 85% | 63.98 | 367 / 430 |
esophagus | 70% | 1359.79 | 1011 / 1445 | 89% | 83.83 | 163 / 183 |
uterus | 86% | 1844.75 | 146 / 170 | 72% | 56.84 | 330 / 459 |
intestine | 87% | 1676.06 | 839 / 966 | 66% | 43.28 | 348 / 527 |
prostate | 97% | 1939.66 | 237 / 245 | 47% | 12.10 | 238 / 502 |
skin | 96% | 4279.56 | 1744 / 1809 | 40% | 18.94 | 188 / 472 |
bladder | 71% | 3475.05 | 15 / 21 | 62% | 35.29 | 311 / 504 |
adrenal gland | 99% | 4668.95 | 256 / 258 | 19% | 11.81 | 44 / 230 |
kidney | 79% | 1012.16 | 70 / 89 | 38% | 20.38 | 345 / 901 |
heart | 72% | 2177.37 | 616 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 69% | 40.18 | 31 / 45 |
spleen | 60% | 564.90 | 144 / 241 | 0% | 0 | 0 / 0 |
adipose | 58% | 1592.62 | 695 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 57% | 1063.80 | 759 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 52% | 19.64 | 15 / 29 |
liver | 28% | 216.68 | 63 / 226 | 5% | 2.14 | 19 / 406 |
brain | 0% | 2.28 | 8 / 2642 | 13% | 5.25 | 90 / 705 |
muscle | 10% | 131.28 | 78 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071559 | Biological process | response to transforming growth factor beta |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
Gene name | MXRA5 |
Protein name | Matrix-remodeling-associated protein 5 (Adhesion protein with leucine-rich repeats and immunoglobulin domains related to perlecan) (Adlican) Alternative protein MXRA5 |
Synonyms | |
Description | FUNCTION: In kidney, has anti-inflammatory and anti-fibrotic properties by limiting the induction of chemokines, fibronectin and collagen expression in response to TGB1 and pro-inflammatory stimuli. . |
Accessions | L8ECG1 ENST00000217939.7 Q9NR99 |